Good question and good on you for asking it honestly.biohack_bella_87 wrote:For those of you who have actually gone deeper into the primary Khavinson literature specifically - are you working from the english-language journal publications, or have you found translation resources for the Russian-language materials
Short answer: the english-language publications from Khavinson's group are real, peer-reviewed, and accessible. Bulletin of Experimental Biology and Medicine carries translated Russian content and you can pull a number of their papers directly through PubMed. Start there. That is your most defensible primary source base.
The broader Russian-language body of work is more of a rabbit hole and the translation quality of whatever summaries are floating around online ranges from decent to actively misleading. I would not build a protocol rationale on anything you cannot verify through a proper journal.
This is probably closer to the truth than most people want to admit. Inpatient administration contexts drive protocol structures in ways that have nothing to do with optimized pharmacodynamics. The 10-day figure getting treated as some sacred mechanistically-derived number in community discussions is exactly the kind of folk wisdom laundering that IronGut is correctly flagging.IronGutPeptideBro wrote:my guess is that a lot of the clinical structuring was practical/administrative as much as mechanistic
The honest answer is we do not have great data on whether burst versus sustained exposure is mechanistically superior for the endpoints being discussed. Anyone claiming otherwise should be showing their work.
This thread is doing what it should. Keep the sourcing rigorous.